Date of Birth: 
Place of Birth: Paris, Île-de-France, France
About Samuel D. Waksal
- Samuel D.
- "Sam" Waksal (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems.
- He is also the founder of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010.
- At ImClone, Waksal led the company to develop the cancer drug Erbitux (cetuximab).
- During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
- He was convicted of several securities violations, served time in federal prison, and was released.
Read more at Wikipedia